Skip to Main Content

Paper Details

A novel adiponectin receptor agonist (AdipoAI) ameliorates type 2 diabetes-associated periodontitis by enhancing autophagy in osteoclasts.
J Periodontal Res
6
2022
3-Methyladenine, AdipoAI, AdipoRon, DIO, LC3A/B, RANKL, RAW 264, T2D, Type 2 diabetes, adiponectin, adiponectin receptor, alveolar bone loss, diabetes, endotoxemia, gingival inflammation, glucose, inflammatory disease, mice, mouse, obesity, osteoclast, osteoclastogenesis, osteoclasts, periodontal, periodontal disease, periodontitis, tartrate, tartrate-resistant acid phosphatase, type 2 diabetes
Author NameAffiliation
Xingwen WuZhongshan Hospital, Fudan University
Xingwen WuTufts University School of Dental Medicine
Yang SunZhongshan Hospital, Fudan University
Renjie CuiInstitutes of Biomedical Sciences, Fudan University
Jin ZhangInstitutes of Biomedical Sciences, Fudan University
Zhekai HuTufts University School of Dental Medicine
Wei BiZhongshan Hospital, Fudan University
Fei YangZhongshan Hospital, Fudan University
Duan MaInstitutes of Biomedical Sciences, Fudan University
Thomas E Van DykeClinical and Translational Research, Forsyth Institute, Harvard School of Dental Medicine
Thomas E Van DykeClinical and Translational Research, Forsyth Institute, Harvard School of Dental Medicine
Qisheng TuTufts University School of Dental Medicine
Qisheng TuTufts University School of Dental Medicine
Youcheng YuZhongshan Hospital, Fudan University
Jake ChenZhongshan Hospital, Fudan University
Jake ChenTufts University School of Medicine. Cell, Tufts University Sackler School of Graduate Biomedical Sciences.
Jake Y ChenZhongshan Hospital, Fudan University
Jake Y ChenTufts University School of Medicine. Cell, Tufts University Sackler School of Graduate Biomedical Sciences.
  • 1 - 18

Datasets

Release 1.2